US vaccine advisers postpone votes on hepatitis B shot, citing discrepancy

Sept 18 (Reuters) - A panel of U.S. vaccine advisers on Thursday postponed two scheduled votes to recommend changes to hepatitis B vaccination timing in infants whose mothers test negative for the infection.

The committee will work on a "slight discrepancy" in the hepatitis B votes and hold the vote on Friday, said Martin Kulldorff, chairman for the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices.

The panel is set to vote on universal hepatitis B testing for all pregnant women as well as whether to delay the first dose of the vaccine until at least one month of age in infants born to hepatitis B-negative mothers.